
Robert Stockton Jones Jr.
Examiner (ID: 3854)
| Most Active Art Unit | 1762 |
| Art Unit(s) | 1796, 1762 |
| Total Applications | 1302 |
| Issued Applications | 945 |
| Pending Applications | 17 |
| Abandoned Applications | 352 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5625931
[patent_doc_number] => 20060264436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Method of Treating a Psychotic Disorder'
[patent_app_type] => utility
[patent_app_number] => 11/460775
[patent_app_country] => US
[patent_app_date] => 2006-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9099
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20060264436.pdf
[firstpage_image] =>[orig_patent_app_number] => 11460775
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/460775 | Method of Treating a Psychotic Disorder | Jul 27, 2006 | Abandoned |
Array
(
[id] => 5662166
[patent_doc_number] => 20060252762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Methods for treatment of multiple sclerosis'
[patent_app_type] => utility
[patent_app_number] => 11/485022
[patent_app_country] => US
[patent_app_date] => 2006-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 16907
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252762.pdf
[firstpage_image] =>[orig_patent_app_number] => 11485022
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/485022 | Methods for treatment of multiple sclerosis | Jul 10, 2006 | Abandoned |
Array
(
[id] => 9950588
[patent_doc_number] => 08999370
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-07
[patent_title] => 'Method to treat and prevent posterior capsule opacification'
[patent_app_type] => utility
[patent_app_number] => 11/913798
[patent_app_country] => US
[patent_app_date] => 2006-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 10785
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11913798
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/913798 | Method to treat and prevent posterior capsule opacification | May 25, 2006 | Issued |
Array
(
[id] => 5368478
[patent_doc_number] => 20090306037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Combination of a Dipeptidyl Peptidase-IV Inhibitor and a Cannabinoid CB1 Receptor Antagonist for the Treatment of Diabetes and Obesity'
[patent_app_type] => utility
[patent_app_number] => 11/919308
[patent_app_country] => US
[patent_app_date] => 2006-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21838
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20090306037.pdf
[firstpage_image] =>[orig_patent_app_number] => 11919308
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/919308 | Combination of a Dipeptidyl Peptidase-IV Inhibitor and a Cannabinoid CB1 Receptor Antagonist for the Treatment of Diabetes and Obesity | Apr 27, 2006 | Abandoned |
| 11/409359 | Novel direct process | Apr 21, 2006 | Abandoned |
Array
(
[id] => 5689038
[patent_doc_number] => 20060287353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Method for preventing or treating ischemia-or hemorrhage-induced brain damage using a macrolide compound'
[patent_app_type] => utility
[patent_app_number] => 11/405679
[patent_app_country] => US
[patent_app_date] => 2006-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1054
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287353.pdf
[firstpage_image] =>[orig_patent_app_number] => 11405679
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/405679 | Method for preventing or treating ischemia-or hemorrhage-induced brain damage using a macrolide compound | Apr 17, 2006 | Abandoned |
Array
(
[id] => 5097040
[patent_doc_number] => 20070118649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'Methods, apparatuses and computer programs for protecting networks against attacks that use forged messages'
[patent_app_type] => utility
[patent_app_number] => 11/404933
[patent_app_country] => US
[patent_app_date] => 2006-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3057
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20070118649.pdf
[firstpage_image] =>[orig_patent_app_number] => 11404933
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/404933 | Methods, apparatuses and computer programs for protecting networks against attacks that use forged messages | Apr 13, 2006 | Abandoned |
| 11/374552 | Hepatocyte growth factor pathway activators in demyelinating diseases and central nervous system trauma | Mar 12, 2006 | Abandoned |
Array
(
[id] => 5700701
[patent_doc_number] => 20060217386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Nutritional preparations'
[patent_app_type] => utility
[patent_app_number] => 11/372245
[patent_app_country] => US
[patent_app_date] => 2006-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11404
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20060217386.pdf
[firstpage_image] =>[orig_patent_app_number] => 11372245
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/372245 | Nutritional preparations | Mar 8, 2006 | Abandoned |
Array
(
[id] => 5149519
[patent_doc_number] => 20070049579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Medicament having neovascularization promoting action'
[patent_app_type] => utility
[patent_app_number] => 11/366454
[patent_app_country] => US
[patent_app_date] => 2006-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2704
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20070049579.pdf
[firstpage_image] =>[orig_patent_app_number] => 11366454
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/366454 | Medicament having neovascularization promoting action | Mar 2, 2006 | Abandoned |
Array
(
[id] => 54128
[patent_doc_number] => 07767682
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-03
[patent_title] => 'Medicaments'
[patent_app_type] => utility
[patent_app_number] => 11/817523
[patent_app_country] => US
[patent_app_date] => 2006-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 6331
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/767/07767682.pdf
[firstpage_image] =>[orig_patent_app_number] => 11817523
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/817523 | Medicaments | Feb 28, 2006 | Issued |
Array
(
[id] => 830201
[patent_doc_number] => 07399755
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-15
[patent_title] => 'Formulations comprising multiple dietary and endogenously made antioxidants and B-vitamins and use of same'
[patent_app_type] => utility
[patent_app_number] => 11/357246
[patent_app_country] => US
[patent_app_date] => 2006-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7724
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/399/07399755.pdf
[firstpage_image] =>[orig_patent_app_number] => 11357246
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/357246 | Formulations comprising multiple dietary and endogenously made antioxidants and B-vitamins and use of same | Feb 16, 2006 | Issued |
Array
(
[id] => 5666640
[patent_doc_number] => 20060171990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'Drug delivery materials made by sol/gel technology'
[patent_app_type] => utility
[patent_app_number] => 11/346983
[patent_app_country] => US
[patent_app_date] => 2006-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13261
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20060171990.pdf
[firstpage_image] =>[orig_patent_app_number] => 11346983
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/346983 | Drug delivery materials made by sol/gel technology | Feb 2, 2006 | Abandoned |
Array
(
[id] => 5700606
[patent_doc_number] => 20060217291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Radiosensitizer'
[patent_app_type] => utility
[patent_app_number] => 11/337557
[patent_app_country] => US
[patent_app_date] => 2006-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5271
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20060217291.pdf
[firstpage_image] =>[orig_patent_app_number] => 11337557
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/337557 | Radiosensitizer | Jan 23, 2006 | Abandoned |
Array
(
[id] => 5777455
[patent_doc_number] => 20060106095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Therapeutic agent for renal failure'
[patent_app_type] => utility
[patent_app_number] => 11/319821
[patent_app_country] => US
[patent_app_date] => 2005-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5094
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20060106095.pdf
[firstpage_image] =>[orig_patent_app_number] => 11319821
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/319821 | Therapeutic agent for renal failure | Dec 27, 2005 | Abandoned |
Array
(
[id] => 4949917
[patent_doc_number] => 20080306043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'Sabcomeline Alone or Combined with a Mood Stabilising or Antimanic Agent to Treat Bipolar Disorders'
[patent_app_type] => utility
[patent_app_number] => 11/792850
[patent_app_country] => US
[patent_app_date] => 2005-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7866
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20080306043.pdf
[firstpage_image] =>[orig_patent_app_number] => 11792850
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/792850 | Sabcomeline Alone or Combined with a Mood Stabilising or Antimanic Agent to Treat Bipolar Disorders | Dec 22, 2005 | Abandoned |
Array
(
[id] => 5866047
[patent_doc_number] => 20060100178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Dermal agent'
[patent_app_type] => utility
[patent_app_number] => 11/304577
[patent_app_country] => US
[patent_app_date] => 2005-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7465
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20060100178.pdf
[firstpage_image] =>[orig_patent_app_number] => 11304577
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/304577 | Dermal agent | Dec 15, 2005 | Abandoned |
Array
(
[id] => 5777417
[patent_doc_number] => 20060106057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Stabilization of quinapril using magnesium oxide'
[patent_app_type] => utility
[patent_app_number] => 11/313123
[patent_app_country] => US
[patent_app_date] => 2005-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4888
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20060106057.pdf
[firstpage_image] =>[orig_patent_app_number] => 11313123
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/313123 | Stabilization of quinapril using magnesium oxide | Dec 14, 2005 | Abandoned |
Array
(
[id] => 5866079
[patent_doc_number] => 20060100210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Methods for treatment of scleroderma'
[patent_app_type] => utility
[patent_app_number] => 11/304519
[patent_app_country] => US
[patent_app_date] => 2005-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16600
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20060100210.pdf
[firstpage_image] =>[orig_patent_app_number] => 11304519
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/304519 | Methods for treatment of scleroderma | Dec 14, 2005 | Abandoned |
Array
(
[id] => 5808349
[patent_doc_number] => 20060094704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Treatment of premature ejaculation'
[patent_app_type] => utility
[patent_app_number] => 11/292713
[patent_app_country] => US
[patent_app_date] => 2005-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7408
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094704.pdf
[firstpage_image] =>[orig_patent_app_number] => 11292713
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/292713 | Treatment of premature ejaculation | Nov 30, 2005 | Abandoned |